Recurrence of Anti-Semaphorin 3B–Mediated Membranous Nephropathy after Kidney Transplantation - Sorbonne Université Accéder directement au contenu
Article Dans Une Revue Journal of the American Society of Nephrology Année : 2022

Recurrence of Anti-Semaphorin 3B–Mediated Membranous Nephropathy after Kidney Transplantation

Résumé

Background Membranous nephropathy (MN) is rare in pediatric patients, although its diagnosis may be underestimated in children who are responsive to corticosteroid therapy prescribed for a suspicion of minimal change disease. It is most often associated with an autoimmune disease, predominantly lupus. We previously reported the occurrence of early-onset MN associated with semaphorin 3B in nine children and two adults. Methods Biopsies were performed on native kidney and at 1 and 5 months after transplantation. Semaphorin 3B antigen was detected in immune deposits by immunohistochemistry and confocal microscopy on paraffin-embedded biopsies. Anti-semaphorin antibodies were detected by Western blot and analyzed sequentially. Results We report the first case of early recurrence after transplantation in a 7-year-old boy who presented with severe nephrotic syndrome and advanced kidney failure. There was no evidence of hereditary or associated autoimmune disease. Abundant, almost coalescent deposits were seen by electron microscopy and bright granular, subepithelial staining was observed for semaphorin 3B antigen. Western blot analysis of serum revealed anti-semaphorin 3B antibodies. Recurrence of MN occurred 25 days after transplantation and manifested as nephrotic range proteinuria despite conventional immunosuppressive therapy. Kidney biopsies confirmed histologic MN recurrence with colocalization of semaphorin 3B antigen and IgG. The patient was treated with rituximab. Anti-semaphorin 3B antibodies, which were detected at transplantation, were not detected 40 days after rituximab. Conclusion This case provides evidence that anti-semaphorin 3B antibodies are pathogenic and should be monitored in patients with MN.
Fichier principal
Vignette du fichier
recurrence_of_anti_semaphorin_3b_mediated.8.pdf (1.57 Mo) Télécharger le fichier
Origine Publication financée par une institution

Dates et versions

hal-03915106 , version 1 (28-09-2023)

Identifiants

Citer

Marc Fila, Hanna Debiec, Hélène Perrochia, Nabila Djouadi, Marie-Christine Verpont, et al.. Recurrence of Anti-Semaphorin 3B–Mediated Membranous Nephropathy after Kidney Transplantation. Journal of the American Society of Nephrology, 2022, 33 (3), pp.503-509. ⟨10.1681/ASN.2021101323⟩. ⟨hal-03915106⟩
44 Consultations
6 Téléchargements

Altmetric

Partager

Gmail Mastodon Facebook X LinkedIn More